title: Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
abstract: Successful stem cell transplantation for patients with severe combined immunodeficiency (SCID) from matched family donors without conditioning results in engraftment of T lymphocytes. B lymphocytes engraft in only 50% of the cases, while myelopoiesis and erythropoiesis remain of host origin. Full hematopoietic engraftment was reported in one case after bone marrow transplantation without conditioning for a SCID patient. We studied three SCID patients who were transplanted with unmodified mobilized peripheral blood from HLA-identical family sex-mismatched members. They received megadoses of stem cells (18-23 x 10(6)CD34/kg). In contrast to the expected mixed chimerism that usually occurs in the absence of conditioning, we found in our patients 100% donor cell engraftment based on fluorescence in situ hybridization (FISH) and microsatellite techniques. Subset analysis of the engrafted cells using a multiparametric system enabling a combined analysis of morphology, immunophenotyping and FISH showed that both T and B lymphocytes and myeloid cells were of donor origin in two patients, while T lymphocytes and myeloid cells were of donor origin in the third. In the two cases with ABO incompatibility, erythroid engraftment was evidenced by blood group conversion from recipient to donor type. Multilineage donor engraftment is possible in SCID patients even without conditioning.
authors.affiliation: Department of Pediatric Hematology-Oncology and BMT and the Institute of Hematology, Sheba Medical Center, Tel-Hashomer, affiliated to the Sackler School of Medicine, Tel-Aviv University, Israel. bellab@sheba.health.gov.il
authors.forename: B
authors.initials: B
authors.lastname: Bielorai
authors.forename: L
authors.initials: L
authors.lastname: Trakhtenbrot
authors.forename: N
authors.initials: N
authors.lastname: Amariglio
authors.forename: R
authors.initials: R
authors.lastname: Rothman
authors.forename: U
authors.initials: U
authors.lastname: Tabori
authors.forename: I
authors.initials: I
authors.lastname: Dallal
authors.forename: H
authors.initials: H
authors.lastname: Golan
authors.forename: Y
authors.initials: Y
authors.lastname: Neumann
authors.forename: M
authors.initials: M
authors.lastname: Reichart
authors.forename: C
authors.initials: C
authors.lastname: Kaplinsky
authors.forename: G
authors.initials: G
authors.lastname: Rechavi
authors.forename: A
authors.initials: A
authors.lastname: Toren
mesh_terms: D001402:B-Lymphocytes / Q000637:transplantation; D016026:Bone Marrow Transplantation / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005190:Family; D005260:Female; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007223:Infant; D017710:Lymphocyte Transfusion; D008297:Male; D016511:Severe Combined Immunodeficiency / Q000276:immunology / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods*; D013601:T-Lymphocytes / Q000637:transplantation; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D006680:HLA Antigens